Press Releases
Curie-Cancer and Harmonic Pharma sign a partnership agreement for...
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Harmonic Pharma, which is developing solutions for extending the therapeutic application of...
Press Releases
Merck Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit...
Merck, known as MSD outside the United States and Canada, today confirmed terms of an agreement with plaintiffs to resolve Plubell v. Merck, an...
Press Releases
Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in...
Genzyme, aSanofi company , announced today the publication of results from the LEMTRADA™ (alemtuzumab) CARE-MS I and CARE-MS II pivotal studies in patients with...
Press Releases
Ariana(R) Pharma and CTCLS sign Japanese distribution agreement for...
Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across life science industries as well as the FDA, today announces...
Press Releases
Adocia announces the strong growth of its turnover
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already approved therapeutic proteins, announces today revenues for the third quarter...
Press Releases
TxCell announces publication of CATS1 study results for antigen-specific...
TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical need, announces today the...
Press Releases
Cytheris announces US Orphan Drug Designation for CYT107 for...
Cytheris SA, a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that the US Food and Drug Administration (FDA) has granted an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.